Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Northwestern University
City of Hope Medical Center
Columbia University
M.D. Anderson Cancer Center
Virginia Commonwealth University